TPST:Tempest Therapeutics Inc - Stock Price Quote and Dividend Data
TPST STOCK PRICE LATEST CLOSE
$7.15
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Tempest Therapeutics Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Tempest Therapeutics Inc Stock Price Information
52-Week Low/High Stock Price$5.35 - $51.28
Percent Held by Institutions44.63%
Revenue$0
Net Income$-55,656,000
Cash Flow$-43,176,000
EPS-0.31%
Market Cap$25,010,700
PE Ratio to Industry123%
Debt-Equity Ratio33.22%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-85.79%
Total Return Last 3 Years-85.18%
Total Return Last 5 Years-97.42%
Latest Trade DateApr. 09, 2025
Tempest Therapeutics Inc Annual Stock Dividends
No Data available for Payment History.
Tempest Therapeutics Inc Dividend Payment History
| No dividends retrieved for TPST |
Tempest Therapeutics Inc Other Dividend Details
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a range of tumors. Its two clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor alpha (PPAR). The ongoing global randomized Phase Ib/II trial of TPST-1120 combined with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC).
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 10, 2025TPST STOCK PRICE INCREASE: Tempest Therapeutics Inc on 04-10-2025 increased stock price > 10% from $0.50 to $7.15
Apr. 08, 2025TPST STOCK PRICE DECREASE: Tempest Therapeutics Inc on 04-08-2025 decreased stock price > 10% from $0.61 to $0.51
Apr. 05, 2025TPST STOCK PRICE DECREASE: Tempest Therapeutics Inc on 04-05-2025 decreased stock price > 10% from $0.72 to $0.61
Jan. 04, 2025TPST STOCK PRICE INCREASE: Tempest Therapeutics Inc on 01-04-2025 increased stock price > 10% from $0.86 to $0.95
Dec. 24, 2024TPST STOCK PRICE INCREASE: Tempest Therapeutics Inc on 12-24-2024 increased stock price > 10% from $0.71 to $0.85
Dec. 19, 2024TPST STOCK PRICE DECREASE: Tempest Therapeutics Inc on 12-19-2024 decreased stock price > 10% from $0.79 to $0.70
Dec. 19, 2024TPST STOCK PRICE 52 WEEK LOW: Tempest Therapeutics Inc on 12-19-2024 hit a 52 week low of $0.70
Nov. 14, 2024TPST STOCK PRICE DECREASE: Tempest Therapeutics Inc on 11-14-2024 decreased stock price > 10% from $1.08 to $0.97
Oct. 31, 2024TPST STOCK PRICE DECREASE: Tempest Therapeutics Inc on 10-31-2024 decreased stock price > 10% from $1.10 to $0.96
Oct. 11, 2024TPST STOCK PRICE DECREASE: Tempest Therapeutics Inc on 10-11-2024 decreased stock price > 10% from $1.35 to $1.10
Apr. 10, 2025AIMI STOCK PRICE DECREASE: AIM ImmunoTech Inc on 04-10-2025 decreased stock price > 10% from $0.04 to $0.03
Apr. 10, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-10-2025 decreased stock price > 10% from $0.27 to $0.20
Apr. 10, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.05
Apr. 10, 2025SLRX STOCK PRICE DECREASE: Com Par $0.0001/Salarius Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.81 to $0.60
Apr. 10, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-10-2025 decreased stock price > 10% from $1.27 to $1.03
Apr. 10, 2025BGLC STOCK PRICE DECREASE: BioNexus Gene Lab Corp on 04-10-2025 decreased stock price > 10% from $2.63 to $2.17
Apr. 10, 2025BFRGW STOCK PRICE DECREASE: Wt Exp/BullFrog AI Holdings Inc on 04-10-2025 decreased stock price > 10% from $0.60 to $0.50
Apr. 10, 2025BEIGF STOCK PRICE DECREASE: BeiGene Ltd on 04-10-2025 decreased stock price > 10% from $19.01 to $15.95
Apr. 10, 2025BIAFW STOCK PRICE DECREASE: Wt Exp/Bioaffinity Technologies Inc on 04-10-2025 decreased stock price > 10% from $0.22 to $0.14
Apr. 10, 2025LEXTF STOCK PRICE DECREASE: Lexston Mining Corp on 04-10-2025 decreased stock price > 10% from $0.22 to $0.17
